Inhibition of ABCC5-mediated cGMP transport by progesterone, testosterone and their analogues
Authors:
Open Access
- 1 October 2021
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 213, 105951
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormonesCell and tissue research, 2012
- Deregulated Hepatic Metabolism Exacerbates Impaired Testosterone Production in Mrp4-deficient MiceJournal of Biological Chemistry, 2012
- Expression of OATP Family Members in Hormone-Related Cancers: Potential Markers of ProgressionPLOS ONE, 2011
- Drug transporter, P-glycoprotein (MDR1), is an integrated component of the mammalian blood–testis barrierThe International Journal of Biochemistry & Cell Biology, 2009
- The Flexible Pocketome Engine for Structural Chemogenomics2009
- Progesterone Action in Human Tissues: Regulation by Progesterone Receptor (PR) Isoform Expression, Nuclear Positioning and Coregulator ExpressionNuclear Receptor Signaling, 2009
- Non-genomic progesterone actions in female reproductionHuman Reproduction Update, 2008
- The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood–testis barrier and in primary testicular tumoursEuropean Journal of Cancer, 2004
- Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligandsJournal of Theoretical Biology, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973